LLY - Lilly to record $111M pre-tax IPR&D charges in Q1
2024-04-05 17:58:39 ET
More on Eli Lilly
- Eli Lilly: Three Threats To Its Huge Rally
- Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
- Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets
- Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end
- Novo’s Ozempic to face copycats as Chinese firm seeks biosimilar nod